DNA合成の市場規模、シェア、動向分析レポート：サービスタイプ別（遺伝子合成、オリゴヌクレオチド合成）、用途別（研究開発、治療薬）、最終用途別、地域別、セグメント予測、2023年～2030年

DNA合成市場の成長と動向

Grand View Research, Inc.の新しいレポートによると、世界のDNA合成市場規模は2030年までに127億6000万米ドルに達すると予測されています。この市場は、患者ケアの決定を支援するパーソナライズドゲノムシーケンスへの注目が高まっていることから、2023年から2030年にかけて19.63%のCAGRを記録すると予想されています。また、DNA合成は、疾病モニタリング、創薬、ファーマコゲノミクスなどの幅広い用途で、生物学的研究活動に革命をもたらす可能性があります。

COVID-19のパンデミックは、COVID-19感染やさまざまな種類のがんの治療のためのmRNAベースのワクチンの採用にプラスの影響を及ぼしました。mRNAの有用性は、合成DNAの需要を押し上げます。さらに、COVID-19研究の主要な焦点はDNA合成です。合成DNAは、すべてのPCR分析で使用されます。患者は、サンプルに含まれる可能性のあるゲノムDNAを特定するために、DNAプライマーを使用する必要があります。

酵素工学の進歩により、酵素的DNA合成のさまざまなアプローチが開発されつつあります。酵素を使用して核酸を必要な配列に連結するもので、広く応用するためにはさらなる最適化が必要です。多くの市場関係者が、ヌクレオチドを最短のターンアラウンドタイムで効率的に酵素生産するための新規技術の考案に努めています。例えば、Ribbon Biolabsは2021年5月に1万塩基対のDNA配列を合成するというミッションを掲げ、2021年12月には2万塩基対のDNA分子というマイルストーンを達成しました。

遺伝子合成は、特定の塩基配列を用いた標的変異誘発や、所望の表現型発現の制御など、幅広い用途に利用されています。遺伝子合成は、遺伝子工学の基礎となるもので、高い特異性を持つ抗体断片の開発により、抗体の種類と品質を飛躍的に向上させました。

オリゴヌクレオチド合成は、必要な確定配列の核酸の比較的短い断片を実験室ベースで製造するものです。この技術は、所望の配列のカスタムメイドのオリゴヌクレオチドを迅速かつ安価に入手することを容易にする、極めて堅牢な手法です。企業は、ヌクレオチド合成プロセスを支援するために、そのオリゴヌクレオチドライブラリーを考案しています。例えば、2022年7月、Ribbon Biolabsは、Ribbon Biolabsの多様なオリゴヌクレオチドライブラリを用いたヌクレオチド分子の合成方法を構成する米国特許を取得したと宣言しています。この方法は、あらかじめオリゴヌクレオチドのライブラリーを構築し、効率的にアクセスできるようにしたものです。

DNA合成市場のレポートハイライト

サービスタイプ別では、研究研究における有用性のために合成ヌクレオチド鎖の需要が高まっていることから、オリゴヌクレオチド合成が2022年に最大のシェアを占めた

用途別では、生物工学やmRNAベースのワクチンなど幅広い用途で合成ヌクレオチドの需要があることから、研究開発分野が2022年に市場を独占しました。

最終用途別では、バイオ分子療法を活用した合成ヌクレオチドの用途の増加により、バイオ製薬会社セグメントが予測期間中に急成長すると予想されます。また、新薬開発の需要の高まりも、このセグメントの成長にプラスの影響を与えます。

北米は、ライフサイエンス研究の進展と新規バイオ治療薬の需要の急増により、2022年の世界市場を独占しました。

アジア太平洋地域は、生物学的研究と新規創薬の需要の増加により、大幅な成長が見込まれています。さらに、主要な市場参加者は、最新のヌクレオチド生産の専門知識をもって、アジア太平洋市場への参入を目指しています。

目次

第1章 調査手法と範囲

• 調査範囲
• 調査手法
• 情報調達
  • 購入したデータベース
  • GVRの内部データベース
  • 二次情報
  • 1次調査
• 情報またはデータ分析
  • データ分析モデル
• 市場の策定と検証
• 目的

第2章 エグゼクティブサマリー

• DNA合成市場：市場の見通し

第3章 市場変数、動向、範囲

• 市場動向と展望
• 傾向分析
  • サービスタイプの動向
  • アプリケーションの動向
  • 最終用途の動向
• 市場セグメンテーションと範囲
• 市場力学
  • 市場促進要因分析
    • 合成生物学の分野における急速な技術進歩
    • 研究開発（R&D）活動への投資の増加
  • 市場抑制要因分析
    • 潜在的なバイオセーフティ、バイオセキュリティ、および倫理的問題
    • 厳格な政府規制とガイドライン
  • 機会分析
• 製品の浸透と成長の見通しマッピング、2022年
• 事業環境分析
  • DNA合成市場：SWOT分析、要因別（政治と法律、経済と技術）
  • ポーターのファイブフォース分析
• 市場シェア分析
  • 会社の規模
  • 製品ポートフォリオ
  • 戦略的イニシアチブ
• 競合情勢
  • 戦略的枠組み
  • 市場参加の分類
    • 新規・新規参入者
    • 成熟したプレーヤーとリーダー

第4章 サービス型ビジネス分析

• オリゴヌクレオチド合成
  • 標準オリゴヌクレオチド合成
  • カスタムオリゴヌクレオチド合成
• 遺伝子合成
  • カスタム遺伝子合成
  • 遺伝子ライブラリーの合成

第5章 アプリケーション分析

• 研究開発
• 診断
• 治療学

第6章 Edn-Use分析

• バイオ医薬品企業
• 学術・調査機関
• 受託調査機関

第7章 地域ビジネス分析

• DNA合成市場：地域変動分析、2022年および2030年
• 北米
  • 米国
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • カナダ
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
• 欧州
  • ドイツ
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • 英国
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • フランス
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • イタリア
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • スペイン
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • デンマーク
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • スウェーデン
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • ノルウェー
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
• アジア太平洋地域
  • 日本
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • 中国
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • インド
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • オーストラリア
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • タイ
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • 韓国
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • ラテンアメリカ（LATAM）
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • ブラジル
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • メキシコ
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • アルゼンチン
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
• 中東およびアフリカ（MEA）
  • 南アフリカ
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • サウジアラビア
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • アラブ首長国連邦
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ
  • クウェート
    • 主要国のダイナミクス
    • 規制の枠組み
    • 競合シナリオ
    • 最近の開発
    • 投資シナリオ

第8章 企業プロファイル

• 企業プロファイル
  • Thermo Fisher Scientific, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Twist Bioscience
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Bioneer Corporation
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Eton Bioscience
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • LGC Biosearch Technologie
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • IBA GmbH
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Eurofins Scientific
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Integrated DNA Technologies, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Quintara Biosciences
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • GenScript Biotech Corporation
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Incidence of Diseases
• Table 4 Global DNA synthesis Market, By Region, 2018 - 2030 (USD Million)
• Table 5 Global DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
• Table 6 Global DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
• Table 7 Global DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
• Table 8 North America DNA synthesis Market, By Country, 2018 - 2030 (USD Million)
• Table 9 North America DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
• Table 10 North America DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
• Table 11 North America DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
• Table 12 U.S. DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
• Table 13 U.S. DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
• Table 14 U.S. DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
• Table 15 Canada DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
• Table 16 Canada DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
• Table 17 Canada DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
• Table 18 Europe DNA synthesis Market, By Country, 2018 - 2030 (USD Million)
• Table 19 Europe DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
• Table 20 Europe DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
• Table 21 Europe DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
• Table 22 Germany DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
• Table 23 Germany DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
• Table 24 Germany DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
• Table 25 U.K. DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
• Table 26 U.K. DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
• Table 27 U.K. DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
• Table 28 France DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
• Table 29 France DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
• Table 30 France DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
• Table 31 Italy DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
• Table 32 Italy DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
• Table 33 Italy DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
• Table 34 Spain DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
• Table 35 Spain DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
• Table 36 Spain DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
• Table 37 Denmark DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
• Table 38 Denmark DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
• Table 39 Denmark DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
• Table 40 Sweden DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
• Table 41 Sweden DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
• Table 42 Sweden DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
• Table 43 Norway DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
• Table 44 Norway DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
• Table 45 Norway DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
• Table 46 Asia Pacific DNA synthesis Market, By Country, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
• Table 50 Japan DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
• Table 51 Japan DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
• Table 52 Japan DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
• Table 53 China DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
• Table 54 China DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
• Table 55 China DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
• Table 56 India DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
• Table 57 India DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
• Table 58 India DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
• Table 59 Australia DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
• Table 60 Australia DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
• Table 61 Australia DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
• Table 62 Thailand DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
• Table 63 Thailand DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
• Table 64 Thailand DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
• Table 65 South Korea DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
• Table 66 South Korea DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
• Table 67 South Korea DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
• Table 68 Latin America DNA synthesis Market, By Country, 2018 - 2030 (USD Million)
• Table 69 Latin America DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
• Table 70 Latin America DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
• Table 71 Latin America DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
• Table 72 Brazil DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
• Table 73 Brazil DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
• Table 74 Brazil DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
• Table 75 Mexico DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
• Table 76 Mexico DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
• Table 77 Mexico DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
• Table 78 Argentina DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
• Table 79 Argentina DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
• Table 80 Argentina DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa DNA synthesis Market, By Country, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
• Table 83 Middle East & Africa DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
• Table 84 Middle East & Africa DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
• Table 85 Saudi Arabia DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
• Table 88 South Africa DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
• Table 89 South Africa DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
• Table 90 South Africa DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
• Table 91 UAE DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
• Table 92 UAE DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
• Table 93 UAE DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)
• Table 94 Kuwait DNA synthesis Market, By Service Type, 2018 - 2030 (USD Million)
• Table 95 Kuwait DNA synthesis Market, By Application, 2018 - 2030 (USD Million)
• Table 96 Kuwait DNA synthesis Market, By End-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 DNA Synthesis Market Segmentation
• Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
• Fig. 10 Penetration & Growth Prospect Mapping
• Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 12 Porter's Five Forces Analysis
• Fig. 13 Market Penetration Vs Growth Prospect Mapping, 2022
• Fig. 14 DNA Synthesis Market: Product Key Takeaways
• Fig. 15 Global DNA Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 16 Global DNA Synthesis Market, for Service Type, 2018 - 2030 (USD Million)
• Fig. 17 Global DNA Synthesis Market, for Oligonucleotide Synthesis, 2018 - 2030 (USD Million)
• Fig. 18 Global DNA Synthesis Market, for Standard Oligonucleotide Synthesis, 2018 - 2030 (USD Million)
• Fig. 19 Global DNA Synthesis Market, for Custom Oligonucleotide Synthesis, 2018 - 2030 (USD Million)
• Fig. 20 Global DNA Synthesis Market, for Gene Synthesis, 2018 - 2030 (USD Million)
• Fig. 21 Global DNA Synthesis Market, for Custom Gene Synthesis, 2018 - 2030 (USD Million)
• Fig. 22 Global DNA Synthesis Market, for Gene Library Synthesis, 2018 - 2030 (USD Million)
• Fig. 23 Global DNA Synthesis Market, for Application, 2018 - 2030 (USD Million)
• Fig. 24 Global DNA Synthesis Market, for Research & Development, 2018 - 2030 (USD Million)
• Fig. 25 Global DNA Synthesis Market, for Diagnostics, 2018 - 2030 (USD Million)
• Fig. 26 Global DNA Synthesis Market, for Therapeutics, 2018 - 2030 (USD Million)
• Fig. 27 Global DNA Synthesis Market, for End-Use, 2018 - 2030 (USD Million)
• Fig. 28 Global DNA Synthesis Market, for Biopharmaceutical Companies, 2018 - 2030 (USD Million)
• Fig. 29 Global DNA Synthesis Market, for Academic & Research Institutes, 2018 - 2030 (USD Million)
• Fig. 30 Global DNA Synthesis Market, for Contract Research Organizations, 2018 - 2030 (USD Million)
• Fig. 31 Global DNA Synthesis Market - Regional Outlook, 2022 & 2030
• Fig. 32 North America DNA Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 33 U.S. DNA Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 34 Canada DNA Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 35 Europe DNA Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 36 Germany DNA Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 37 U.K. DNA Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 38 France DNA Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 39 Italy DNA Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 40 Spain DNA Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 41 Denmark DNA Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 42 Sweden DNA Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 43 Norway DNA Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 44 Asia Pacific DNA Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 45 Japan DNA Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 46 China DNA Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 47 India DNA Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 48 Australia DNA Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 49 Thailand DNA Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 50 South Korea DNA Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 51 Latin America DNA Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 52 Brazil DNA Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 53 Mexico DNA Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 54 Argentina DNA Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 55 Middle East and Africa DNA Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 56 South Africa DNA Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 57 Saudi Arabia DNA Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 58 UAE DNA Synthesis Market, 2018 - 2030 (USD Million)
• Fig. 59 Kuwait DNA Synthesis Market, 2018 - 2030 (USD Million)

DNA Synthesis Market Growth & Trends:

The global DNA synthesis market size is expected to reach USD 12.76 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 19.63% from 2023 to 2030 owing to the rising focus on personalized genome sequencing that aids determine patient care. In addition, DNA synthesis has the capability to revolutionize biological research activities for widespread applications in disease monitoring, drug discovery, and pharmacogenomics.

The COVID-19 pandemic positively impacted the adoption of mRNA-based vaccines for the treatment of COVID-19 infection and different types of cancers. The utility of mRNA boosts the demand for synthetic DNA. Furthermore, a major focus of COVID-19 research is DNA synthesis. Synthetic DNA is used in all PCR analyses. Patients need to use a DNA primer to identify any genomic DNA that may be present in the sample.

Progress in enzyme engineering is boosting the development of different approaches for enzymatic DNA synthesis. It involves the use of enzymes to chain the nucleic acids together in the required sequence and requires further optimization for its widespread applications. Many market players are striving to devise novel technologies for efficient enzymatic production of nucleotides in the lowest turnaround time. For instance, in May 2021, Ribbon Biolabs set a mission of synthesizing DNA sequences of 10,000 base pairs and accomplished a milestone of a 20,000 base pair DNA molecule by December 2021.

Gene synthesis has a broad spectrum of applications in targeted mutagenesis with a specific sequence of nucleotides along with the regulation of a desired phenotypic expression. It forms the primary basis of genetic engineering, which has significantly leveraged the scope and quality of antibodies by the development of antibody fragments with high specificity.

Oligonucleotide synthesis is the laboratory-based production of relatively short fragments of nucleic acids in a required definitive sequence. The technique is an extremely robust practice that facilitates rapid and inexpensive access to the custom-made oligonucleotides of the desired sequence. Companies have devised their oligonucleotide libraries to aid their nucleotide synthesis processes. For instance, in July 2022, Ribbon Biolabs declared that it secured a U.S. Patent that comprises Ribbon Biolabs' method for the synthesis of a nucleotide molecule using a diverse library of oligonucleotides. The approach comprises a pre-built library of oligonucleotides for efficient access.

DNA Synthesis Market Report Highlights:

• By service type, oligonucleotide synthesis held the largest share in 2022 due to the rising demand for synthetic nucleotide strands for their utility in research studies

• By application, the research and development segment dominated the market in 2022 due to the demand for synthetic nucleotides for a wide spectrum of applications in bioengineering and mRNA-based vaccines

• By end-use, the biopharmaceutical companies segment is expected to grow rapidly over the forecast period owing to a rise in the applications of synthetic nucleotides to leverage bio-molecular therapies. The rise in the demand for novel drug discovery also positively impacts the growth of this segment

• North America dominated the global market in 2022 owing to emerging advancements in life sciences research and rapidly growing demand for novel bio-therapeutics in the region

• Asia Pacific is expected to grow considerably due to a rise in the demand for biological research and novel drug discovery. Moreover, key market players are working towards entering the Asia Pacific market with their modern nucleotide production expertise

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Research Scope
  • 1.1.1 Estimates and Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database
  • 1.3.2 GVR's Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary Research
• 1.4 Information or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Objectives
  • 1.6.1 Objective 1
  • 1.6.2 Objective 2

Chapter 2 Executive Summary

• 2.1 DNA synthesis Market: Market Outlook

Chapter 3 Market Variables, Trends & Scope

• 3.1 Market Trends & Outlook
• 3.2 Trend Analysis
  • 3.2.1 Service Type Trends
  • 3.2.2 Application Trends
  • 3.2.3 End-Use Trends
• 3.3 Market Segmentation & Scope
• 3.4 Market Dynamics
  • 3.4.1 Market driver analysis
    • 3.4.1.1 Rapid Technological Advancements in the Field of Synthetic Biology
    • 3.4.1.2 Rising Investments Toward Research & Development (R&D) Activities
  • 3.4.2 Market restraint analysis
    • 3.4.2.1 Potential Biosafety, Biosecurity, and Ethical Issues
    • 3.4.2.2 Stringent Government Regulations & Guidelines
  • 3.4.3 Opportunity analysis
• 3.5 Penetration & Growth Prospect Mapping for Products, 2022
• 3.6 Business Environment Analysis
  • 3.6.1 DNA synthesis Market -SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
  • 3.6.2 Porter's Five Forces Analysis
• 3.7 Market Share Analysis
  • 3.7.1 Company Size
  • 3.7.2 Product portfolio
  • 3.7.3 Strategic Initiatives
• 3.8 Competitive Landscape
  • 3.8.1 Strategy Framework
  • 3.8.2 Market Participation Categorization
    • 3.8.2.1 New/ emerging entrants
    • 3.8.2.2 Mature players & leaders

Chapter 4 Services Type Business Analysis

• 4.1 Oligonucleotide Synthesis
  • 4.1.1 Global DNA synthesis market for oligonucleotide synthesis, 2018 - 2030 (USD Million)
  • 4.1.2 Standard Oligonucleotide Synthesis
    • 4.1.2.1 Global DNA synthesis market for standard oligonucleotide synthesis, 2018 - 2030 (USD Million)
  • 4.1.3 Custom Oligonucleotide Synthesis
    • 4.1.3.1 Global DNA synthesis market for custom oligonucleotide synthesis, 2018 - 2030 (USD Million)
• 4.2 Gene Synthesis
  • 4.2.1 Global DNA synthesis market for gene synthesis, 2018 - 2030 (USD Million)
  • 4.2.2 Custom Gene Synthesis
    • 4.1.2.1 Global DNA synthesis market for custom gene synthesis, 2018 - 2030 (USD Million)
  • 4.2.3 Gene Library Synthesis
    • 4.1.3.1 Global DNA synthesis market for gene library synthesis, 2018 - 2030 (USD Million)

Chapter 5 Application Analysis

• 5.1 Research & Development
  • 5.1.1 Global DNA Synthesis Market For Research & Development, 2018 - 2030 (USD Million)
• 5.2 Diagnostics
  • 5.2.1 Global DNA Synthesis Market For Diagnostics, 2018 - 2030 (USD Million)
• 5.3 Therapeutics
  • 5.3.1 Global DNA Synthesis Market For Therapeutics, 2018 - 2030 (USD Million)

Chapter 6 Edn-Use Analysis

• 6.1 Biopharmaceutical Companies
  • 6.1.1 Global DNA Synthesis Market For Biopharmaceutical Companies, 2018 - 2030 (Usd Million)
• 6.2 Academic & Research Institutes
  • 6.2.1 Global DNA Synthesis Market For Academic& Research Institutes, 2018 - 2030 (Usd Million)
• 6.3 Contract Research Organizations
  • 6.3.1 Global DNA Synthesis Market For Contract Research Organizations, 2018 - 2030 (Usd Million)

Chapter 7 Regional Business Analysis

• 7.1 DNA synthesis Market: Regional Movement Analysis, 2022 & 2030
• 7.2 North America
  • 7.2.1 North America Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • 7.2.2 U.S.
    • 7.2.2.1 U.S. Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.2.2.2 Key country Dynamics
    • 7.2.2.3 Regulatory Framework
    • 7.2.2.4 Competitive Scenario
    • 7.2.2.5 Recent Developments
    • 7.2.2.6 Investments Scenario
  • 7.2.3 Canada
    • 7.2.3.1 Canada Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.2.3.2 Key country Dynamics
    • 7.2.3.3 Regulatory Framework
    • 7.2.3.4 Competitive Scenario
    • 7.2.3.5 Recent Developments
    • 7.2.3.6 Investments Scenario
• 7.3 Europe
  • 7.3.1 Europe Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • 7.3.2 Germany
    • 7.3.2.1 Germany Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.3.2.2 Key country Dynamics
    • 7.3.2.3 Regulatory Framework
    • 7.3.2.4 Competitive Scenario
    • 7.3.2.5 Recent Developments
    • 7.3.2.6 Investments Scenario
  • 7.3.3 U.K.
    • 7.3.3.1 U.K. Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.3.3.2 Key country Dynamics
    • 7.3.3.3 Regulatory Framework
    • 7.3.3.4 Competitive Scenario
    • 7.3.3.5 Recent Developments
    • 7.3.3.6 Investments Scenario
  • 7.3.4 France
    • 7.3.4.1 France Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.3.4.2 Key country Dynamics
    • 7.3.4.3 Regulatory Framework
    • 7.3.4.4 Competitive Scenario
    • 7.3.4.5 Recent Developments
    • 7.3.4.6 Investments Scenario
  • 7.3.5 Italy
    • 7.3.5.1 Italy Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.3.5.2 Key country Dynamics
    • 7.3.5.3 Regulatory Framework
    • 7.3.5.4 Competitive Scenario
    • 7.3.5.5 Recent Developments
    • 7.3.5.6 Investments Scenario
  • 7.3.6 Spain
    • 7.3.6.1 Spain Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.3.6.2 Key country Dynamics
    • 7.3.6.3 Regulatory Framework
    • 7.3.6.4 Competitive Scenario
    • 7.3.6.5 Recent Developments
    • 7.3.6.6 Investments Scenario
  • 7.3.7 Denmark
    • 7.3.7.1 Italy Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.3.7.2 Key country Dynamics
    • 7.3.7.3 Regulatory Framework
    • 7.3.7.4 Competitive Scenario
    • 7.3.7.5 Recent Developments
    • 7.3.7.6 Investments Scenario
  • 7.3.8 Sweden
    • 7.3.8.1 Italy Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.3.8.2 Key country Dynamics
    • 7.3.8.3 Regulatory Framework
    • 7.3.8.4 Competitive Scenario
    • 7.3.8.5 Recent Developments
    • 7.3.8.6 Investments Scenario
  • 7.3.9 Norway
    • 7.3.9.1 Norway Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.3.9.2 Key country Dynamics
    • 7.3.9.3 Regulatory Framework
    • 7.3.9.4 Competitive Scenario
    • 7.3.9.5 Recent Developments
    • 7.3.9.6 Investments Scenario
• 7.4 Asia Pacific
  • 7.4.1 Asia Pacific Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • 7.4.2 Japan
    • 7.4.2.1 Japan Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.4.2.2 Key country Dynamics
    • 7.4.2.3 Regulatory Framework
    • 7.4.2.4 Competitive Scenario
    • 7.4.2.5 Recent Developments
    • 7.4.2.6 Investments Scenario
  • 7.4.3 China
    • 7.4.3.1 China Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.4.3.2 Key country Dynamics
    • 7.4.3.3 Regulatory Framework
    • 7.4.3.4 Competitive Scenario
    • 7.4.3.5 Recent Developments
    • 7.4.3.6 Investments Scenario
  • 7.4.4 India
    • 7.4.4.1 India Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.4.4.2 Key country Dynamics
    • 7.4.4.3 Regulatory Framework
    • 7.4.4.4 Competitive Scenario
    • 7.4.4.5 Recent Developments
    • 7.4.4.6 Investments Scenario
  • 7.4.5 Australia
    • 7.4.5.1 Australia Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.4.5.2 Key country Dynamics
    • 7.4.5.3 Regulatory Framework
    • 7.4.5.4 Competitive Scenario
    • 7.4.5.5 Recent Developments
    • 7.4.5.6 Investments Scenario
  • 7.4.6 Thailand
    • 7.4.6.1 Thailand Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.4.6.2 Key country Dynamics
    • 7.4.6.3 Regulatory Framework
    • 7.4.6.4 Competitive Scenario
    • 7.4.6.5 Recent Developments
    • 7.4.6.6 Investments Scenario
  • 7.4.7 South Korea
    • 7.4.7.1 South Korea Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.4.7.2 Key country Dynamics
    • 7.4.7.3 Regulatory Framework
    • 7.4.7.4 Competitive Scenario
    • 7.4.7.5 Recent Developments
    • 7.4.7.6 Investments Scenario
• 7.5 Latin America (LATAM)
  • 7.5.1 Latin America Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.5.1.2 Key country Dynamics
    • 7.5.1.3 Regulatory Framework
    • 7.5.1.4 Competitive Scenario
    • 7.5.1.5 Recent Developments
    • 7.5.1.6 Investments Scenario
  • 7.5.2 Brazil
    • 7.5.2.1 Brazil Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.5.2.2 Key country Dynamics
    • 7.5.2.3 Regulatory Framework
    • 7.5.2.4 Competitive Scenario
    • 7.5.2.5 Recent Developments
    • 7.5.2.6 Investments Scenario
  • 7.5.3 Mexico
    • 7.5.3.1 Mexico Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.5.3.2 Key country Dynamics
    • 7.5.3.3 Regulatory Framework
    • 7.5.3.4 Competitive Scenario
    • 7.5.3.5 Recent Developments
    • 7.5.3.6 Investments Scenario
  • 7.5.4 Argentina
    • 7.5.4.1 Argentina Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.5.4.2 Key country Dynamics
    • 7.5.4.3 Regulatory Framework
    • 7.5.4.4 Competitive Scenario
    • 7.5.4.5 Recent Developments
    • 7.5.4.6 Investments Scenario
• 7.6 Middle East and Africa (MEA)
  • 7.6.1 Middle East and Africa Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • 7.6.2 South Africa
    • 7.6.2.1 South Africa Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.6.2.2 Key country Dynamics
    • 7.6.2.3 Regulatory Framework
    • 7.6.2.4 Competitive Scenario
    • 7.6.2.5 Recent Developments
    • 7.6.2.6 Investments Scenario
  • 7.6.3 Saudi Arabia
    • 7.6.3.1 Saudi Arabia Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.6.3.2 Key country Dynamics
    • 7.6.3.3 Regulatory Framework
    • 7.6.3.4 Competitive Scenario
    • 7.6.3.5 Recent Developments
    • 7.6.3.6 Investments Scenario
  • 7.6.4 UAE
    • 7.6.4.1 Saudi Arabia Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.6.4.2 Key country Dynamics
    • 7.6.4.3 Regulatory Framework
    • 7.6.4.4 Competitive Scenario
    • 7.6.4.5 Recent Developments
    • 7.6.4.6 Investments Scenario
  • 7.6.5 Kuwait
    • 7.6.5.1 Kuwait Market Estimates and Forecast, 2018 - 2030 (USD Million)
    • 7.6.5.2 Key country Dynamics
    • 7.6.5.3 Regulatory Framework
    • 7.6.5.4 Competitive Scenario
    • 7.6.5.5 Recent Developments
    • 7.6.5.6 Investments Scenario

Chapter 8 Company Profiles

• 8.1 Company Profiles
  • 8.1.1 Thermo Fisher Scientific, Inc.
    • 8.1.1.1 Company Overview
    • 8.1.1.2 Financial Performance
    • 8.1.1.3 Product Benchmarking
    • 8.1.1.4 Strategic Initiatives
  • 8.1.2 Twist Bioscience
    • 8.1.2.1 Company Overview
    • 8.1.2.2 Financial Performance
    • 8.1.2.3 Product Benchmarking
    • 8.1.2.4 Strategic Initiatives
  • 8.1.3 Bioneer Corporation
    • 8.1.3.1 Company Overview
    • 8.1.3.2 Financial Performance
    • 8.1.3.3 Product Benchmarking
    • 8.1.3.4 Strategic Initiatives
  • 8.1.4 Eton Bioscience
    • 8.1.4.1 Company Overview
    • 8.1.4.2 Financial Performance
    • 8.1.4.3 Product Benchmarking
    • 8.1.4.4 Strategic Initiatives
  • 8.1.5 LGC Biosearch Technologie
    • 8.1.5.1 Company Overview
    • 8.1.5.2 Financial Performance
    • 8.1.5.3 Product Benchmarking
    • 8.1.5.4 Strategic Initiatives
  • 8.1.6 IBA GmbH
    • 8.1.6.1 Company Overview
    • 8.1.6.1 Financial Performance
    • 8.1.6.2 Product Benchmarking
    • 8.1.6.3 Strategic Initiatives
  • 8.1.7 Eurofins Scientific
    • 8.1.7.1 Company Overview
    • 8.1.7.2 Financial Performance
    • 8.1.7.3 Product Benchmarking
    • 8.1.7.4 Strategic Initiatives
  • 8.1.8 Integrated DNA Technologies, Inc.
    • 8.1.8.1 Company Overview
    • 8.1.8.2 Financial Performance
    • 8.1.8.3 Product Benchmarking
    • 8.1.8.4 Strategic Initiatives
  • 8.1.9 Quintara Biosciences
    • 8.1.9.1 Company Overview
    • 8.1.9.2 Financial Performance
    • 8.1.9.3 Product Benchmarking
    • 8.1.9.4 Strategic Initiatives
  • 8.1.10 GenScript Biotech Corporation
    • 8.1.10.1 Company Overview
    • 8.1.10.2 Financial Performance
    • 8.1.10.3 Product Benchmarking
    • 8.1.10.4 Strategic Initiatives